Merck Flexeril
Executive Summary
Rx-to-OTC switch of Merck's muscle relaxant Flexeril 5 mg (cyclobenzaprine, NDA 21-070) will be the topic of a July 20 joint meeting of FDA's Nonprescription Drugs and Arthritis Advisory Committees. The meeting will begin at 8:30 a.m. at the Holiday Inn in Gaithersburg, Md